Combining legal expertise and deep industry knowledge, we aim to bring fresh insights and deliver commercial solutions to our clients. By shaping the conversation in our sectors, we enable our clients to unlock growth, protect innovation and accelerate ambition.
Our capital markets practice advises issuers, underwriters, and investors on a full spectrum of equity and debt capital markets transactions in Hong Kong and internationally, including IPOs on HKEX and NASDAQ, secondary listings, rights issues, placings, and debt financing. We have worked with major investment banks including UBS, Goldman Sachs, BNP Paribas, Merrill Lynch, Deutsche Bank, and Citigroup.
Our M&A practice provides comprehensive advisory services on public and private mergers, acquisitions, disposals, and joint ventures across Asia and internationally. We have advised on landmark transactions including JD.com's acquisition of Kai Bo Food Supermarket — recognised as a China Deals of the Year 2025 — and numerous other high-profile cross-border deals.
Our private equity practice advises PE sponsors, VC funds, and portfolio companies on the full investment lifecycle — from fund formation and initial investment through to exit. We have advised on investments ranging from seed-stage venture capital to large-scale private equity transactions, including pre-IPO investments in China Evergrande Group and I-Mab.
Our investment funds practice advises on the structuring and establishment of a wide range of investment vehicles, including venture capital funds, private equity funds, hedge funds, and family office structures. We assist fund managers and investors with all aspects of fund formation, from drafting constitutional documents to advising on regulatory requirements.
We provide bespoke legal solutions for family offices, high-net-worth individuals, and wealth management institutions across Asia. Our private wealth practice covers the establishment and structuring of family offices, estate planning, trust structures, and cross-border wealth management arrangements.
Our regulation and compliance practice assists listed companies, financial institutions, and other regulated entities with their ongoing regulatory obligations in Hong Kong. We have advised major listed companies including Alibaba Health (HKEX: 0241), Alibaba Group (HKEX: 9988), and China Wangwang (HKEX: 0151) on their post-listing regulatory and compliance matters.
Our general corporate practice advises clients on a broad range of day-to-day corporate matters, from company formation and corporate governance to commercial contracts and joint ventures. We serve as trusted advisors to our clients, providing practical and commercially-focused legal advice that helps them manage and grow their businesses in Hong Kong and across Asia.
Our China practice advises on cross-border transactions involving Chinese parties, including outbound investments, inbound acquisitions, and Hong Kong listings by Mainland Chinese companies. With deep knowledge of both Hong Kong and PRC regulatory frameworks, and Mandarin-speaking lawyers on our team, we bridge the gap between Chinese and international business.
Advising banks, asset managers, insurers, and fintech companies on regulatory matters, M&A, capital raising, and fund structuring across Asia.
Supporting PE/VC-backed technology companies, digital businesses, and startups from seed funding through to IPO and beyond.
Acting for property developers, infrastructure funds, and institutional investors on acquisitions, joint ventures, and financing across the region.
Advising on M&A, investments, and regulatory matters for consumer brands and retailers — including JD.com's landmark acquisition of Kai Bo Food Supermarket.
Providing legal support for biotech, pharmaceutical, and healthcare companies on investments, listings, licensing, and regulatory compliance.
Supporting Chinese and international companies on cross-border energy transactions, outbound investments, and Belt & Road related matters.